Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06455644

Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion

Led by First Affiliated Hospital of Shantou University Medical College · Updated on 2024-06-12

238

Participants Needed

5

Research Sites

365 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study is a prospective, multi-center, randomized controlled trial. The subjects are patients scheduled to undergo a combined procedure of atrial fibrillation (AF) ablation and left atrial appendage (LAA) occlusion. After signing the informed consent form, the subjects will be randomly assigned to either the cardiac Computed Tomography (CT) group or the Digital Subtraction Angiography (DSA) group. The operator will select the appropriate LAA occluder size for implantation based on different measurement methods. All subjects will undergo clinical follow-up before discharge and at 3 months postoperatively, as well as telephone follow-up 1-5 years after the surgery.

CONDITIONS

Official Title

Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Diagnosed with non-valvular atrial fibrillation and scheduled for atrial fibrillation ablation and percutaneous left atrial appendage occlusion
  • Able to understand the trial purpose, willing to participate, and have signed informed consent
  • Willing to complete follow-up according to the study protocol
Not Eligible

You will not qualify if you...

  • Allergy to contrast agents or conditions preventing cardiac CT or DSA imaging
  • Lack of clear images to measure the left atrial appendage diameter on CT scans
  • Presence of blood clots in the left atrium or left atrial appendage on imaging
  • Valvular atrial fibrillation such as mechanical valve replacement or moderate to severe mitral stenosis with atrial fibrillation
  • Left atrial appendage depth less than 15 mm, or anchor zone diameter less than 10 mm or greater than 33 mm
  • Female patients of childbearing age planning pregnancy during the study follow-up
  • Currently enrolled in another clinical trial that may interfere with this study
  • Any other condition deemed unsuitable by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Foshan Nanhai District People's Hospital

Foshan, Guangdong, China

Not Yet Recruiting

2

The Second People's Hospital of Foshan

Foshan, Guangdong, China

Not Yet Recruiting

3

Meizhou Hospital of Traditional Chinese Medicine

Meizhou, Guangdong, China

Not Yet Recruiting

4

First Affiliated Hospital of Shantou University Medical College

Shantou, Guangdong, China

Actively Recruiting

5

Guangdong Provincial Zhongshan Hospital of Traditional Chinese Medicine

Zhongshan, Guangdong, China

Not Yet Recruiting

Loading map...

Research Team

Z

Zhongbo Xiao, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here